Sharekhan

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Par Drugs and Chemicals Ltd

Your Vote -

Buy

78.95%

Hold

5.26%

Sell

15.79%

78.95%

19 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

0%

Sell Order Quantity

100%

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Bid Price

Qty

83.98

205

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

205

Option Chain

Analyzes market sentiment, predicts Par Drugs and Chemicals Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Par Drugs & Chem. - Copy of Newspaper Publication

    15 May 2026, 2:56PM Par Drugs And Chemicals Limited has informed the Exchange about Copy of Newspaper Publication
  • Par Drugs & Chem. Q4 net profit down 48.48% at Rs 0.85 cr

    14 May 2026, 7:50PM The company reported standalone net profit of Rs 0.85 crore for the quarter ended March 31, 2026 as compared to Rs 1.65 crore in the same period last
  • Par Drugs & Chem. - Outcome of Board Meeting

    14 May 2026, 7:12PM Par Drugs And Chemicals Limited has informed the Exchange regarding Outcome of Board Meeting held on May 14, 2026.
  • Par Drugs & Chem. - Updates

    14 May 2026, 6:47PM Par Drugs And Chemicals Limited has informed the Exchange regarding 'Outcome of Board Meeting 14.05.2026'.
  • Par Drugs & Chem. - Updates

    14 May 2026, 6:32PM Par Drugs And Chemicals Limited has informed the Exchange regarding 'Outcome of the Board Meeting dated 14.05.2026'.
  • Par Drugs & Chem. - Outcome of Board Meeting

    14 May 2026, 6:29PM Par Drugs And Chemicals Limited has informed the Exchange regarding Outcome of Board Meeting held on May 14, 2026.
  • Par Drugs & Chem. - Outcome of Board Meeting

    14 May 2026, 6:26PM Par Drugs And Chemicals Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
  • Par Drugs & Chem. has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2026

    19 Apr 2026, 8:00AM As of March 2026, 73.41% is owned by Indian Promoters and 26.59% by Public. <p align=justify> Top five Promoters holding highest number of shares of P
  • Par Drugs & Chem. - Disclosure under SEBI Takeover Regulations

    8 Apr 2026, 4:01PM Par Drugs And Chemicals Limitedÿhas Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of Indi
  • Par Drugs & Chem. - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    7 Apr 2026, 12:14PM Par Drugs And Chemicals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
  • Par Drugs & Chem. - Trading Window

    26 Mar 2026, 4:54PM Par Drugs And Chemicals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regul
  • Par Drugs & Chem. - Action(s) taken or orders passed

    26 Mar 2026, 3:26PM Par Drugs And Chemicals Limited has informed the Exchange about Action(s) taken or orders passed

Key fundamentals

Evaluate the intrinsic value of Par Drugs and Chemicals Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 98.9749 85.632 71.2383 59.8772 59.8542
Liabilities 98.9749 85.632 71.2383 59.8772 59.8542
Equity 12.3046 12.3046 12.3046 12.3046 6.1523
Gross Profit 19.5013 22.8175 18.2073 16.2547 16.0127
Net Profit 13.3579 14.501 11.3341 9.2133 11.6112
Cash From Operating Activities 16.1602 20.2489 13.377 7.6152 12.085
NPM(%) 13.22 15.16 11.83 12.27 19.11
Revenue 100.9735 95.6404 95.7488 75.0744 60.7513
Expenses 81.4722 72.8229 77.5415 58.8197 44.7385
ROE(%) 12 13.03 10.18 8.28 10.43

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day
10 Jul 2020 1.25 12.5 0 35

Peers

Other companies within the same industry or sector that are comparable to Par Drugs and Chemicals Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 708.95 -1.65 0.00 0.00 -26.19 0.71
Lotus Eye Hospital and Institute Ltd 104.74 -1.71 337.87 0.00 3.55 0.00
Vaishali Pharma Ltd 7.00 -0.99 0.00 0.00 3.13 0.00
Astec Lifesciences Ltd 754.75 11.68 0.00 0.00 -363.15 0.00

Company Info

The Company was originally incorporated as "Par Drugs and Chemicals Private Limited" at Bhavnagar, Gujarat as a Private Limited Company under the provisions of the Companies Act, 1956 vide Certificate of Incorporation dated February 26, 1999 bearing Registration Number 04-35512 of 1998-99 issued by the Registrar of Companies, Gujarat, Dadra & Nagar Haveli. Subsequently, the Company was converted into a Public Limited Company pursuant to special resolution passed by the members in Extra-ordinary General Meeting of the Company held on October 24, 2018 and the name of the Company was changed to "Par Drugs and Chemicals Limited" and a fresh certificate of incorporation consequent upon Conversion of Private Company to Public Limited dated November 5, 2018 was issued by the Registrar of Companies, Ahmedabad. The Corporate Identification Number of the Company is U24117GJ1999PLC035512.KEY EVENTS AND MILESTONES IN THE HISTORY OF THE COMPANY1999- Incorporated as a Private Limited Company with the name `Par Drugs and Chemicals Private Limited'1999- Acquisition of the ongoing business of the M/s. Par In Organic2018- Conversion of the Company from Private Limited to Public Limited 2018 -Company converted from Private Limited to Limited. 2019 -The Company has successfully come up with an Initial Public Offer (IPO) of 16,72,000 Equity Shares of face value of 10 each. 2021 -The Company has issued Bonus Shares in the Ratio of 1:1. 2022 - GST Certificate of Appriciation.

The Company was originally incorporated as "Par Drugs and Chemicals Private Limited" at Bhavnagar, Gujarat as a Private Limited Company under the provisions of the Companies Act, 1956 vide Certificate of Incorporation dated February 26, 1999 bearing Registration Number 04-35512 of 1998-99 issued by the Registrar of Companies, Gujarat, Dadra & Nagar Haveli. Subsequently, the Company was converted into a Public Limited Company pursuant to special resolution passed by the members in Extra-ordinary General Meeting of the Company held on October 24, 2018 and the name of the Company was changed to "Par Drugs and Chemicals Limited" and a fresh certificate of incorporation consequent upon Conversion of Private Company to Public Limited dated November 5, 2018 was issued by the Registrar of Companies, Ahmedabad. The Corporate Identification Number of the Company is U24117GJ1999PLC035512.KEY EVENTS AND MILESTONES IN THE HISTORY OF THE COMPANY1999- Incorporated as a Private Limited Company with the name `Par Drugs and Chemicals Private Limited'1999- Acquisition of the ongoing business of the M/s. Par In Organic2018- Conversion of the Company from Private Limited to Public Limited 2018 -Company converted from Private Limited to Limited. 2019 -The Company has successfully come up with an Initial Public Offer (IPO) of 16,72,000 Equity Shares of face value of 10 each. 2021 -The Company has issued Bonus Shares in the Ratio of 1:1. 2022 - GST Certificate of Appriciation.

Read More

Parent Organisation

Par Drugs & Chemicals Ltd.

Founded

26/02/1999

Managing Director

Mr.Jignesh Vallabhbhai Savani

NSE Symbol

PAREQ

FAQ

The current price of Par Drugs and Chemicals Ltd is

The 52-week high for Par Drugs and Chemicals Ltd is

The market capitalization of Par Drugs and Chemicals Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Par Drugs and Chemicals Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Par Drugs and Chemicals Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Par Drugs and Chemicals Ltd shares.

The CEO of Par Drugs and Chemicals Ltd is Mr.Jignesh Vallabhbhai Savani, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT